This phosphorylation reduces sterol binding to Insig1/2, thereby activating SREBP1/2 and promoting SREBP1/2‐mediated transcription of lipogenic genes that support tumor development.[15, 16] Transcription factors, including SREBP, have long been considered untargetable for cancer treatment. Here, SREBF1 is linked to neoplasm.